drugset / Trial / NCT06212089
Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study to evaluate the safety and pharmacokinetics of TR-012001 in patients with Parkinson's disease when TR-012001 or placebo is administered.
Timeline
- Start
- 2023-09-28
- Primary completion
- 2024-04-26
- Completion
- 2024-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TR-012001 | Unknown | — | — |